Sign In
Buy MRNA
$59.81
+0.640 (+1.08%)
At Close: Aug 10, 2026
Top Stock Movers Now: Ford, Cleveland-Cliffs, Moderna, and More
12:15pm, Monday, 02'nd Jun 2025
U.S. equities were mixed at midday after China hit back at the U.S. and accused Washington of violating a trade deal the two countries reached last month. President Donald Trump said on Friday that Ch
Moderna moves higher on FDA approval of new COVID-19 vaccine
11:38am, Monday, 02'nd Jun 2025
Moderna Inc (NASDAQ:MRNA, ETR:0QF) shares edged higher after the US Food and Drug Administration (FDA) approved its newest COVID-19 vaccine mNEXSPIKE (mRNA-1283). The vaccine was approved for use in a
Moderna Stock Is Rising. A New Covid Vaccine Is Coming for Some People.
08:37am, Monday, 02'nd Jun 2025
Moderna said mNEXSPIKE was approved by the FDA for use in adults aged 65 and up, as well as some individuals aged 12 to 64.
Moderna's New COVID Vaccine Secures FDA-Clearance For Seniors, At-Risk Individuals
08:35am, Monday, 02'nd Jun 2025
The U.S. Food and Drug Administration (FDA) on Saturday approved Moderna, Inc.'s MRNA mNexspike (mRNA-1283), a new vaccine against COVID-19, for all adults 65 and older and individuals aged 12-64 yea
US FDA approves Moderna's next-gen COVID vaccine for adults 65 or older
12:34am, Saturday, 31'st May 2025
The U.S. Food and Drug Administration has approved Moderna's next-generation COVID-19 vaccine for all individuals aged 65 and above, the company said on Saturday, the first endorsement since the regul
Moderna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE
12:16am, Saturday, 31'st May 2025
mNEXSPIKE becomes Moderna's third FDA-approved product CAMBRIDGE, MA / ACCESS Newswire / May 31, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has
Moderna, Inc. (MRNA) Bernstein 41st Annual Strategic Decisions Conference Call Transcript
03:15pm, Thursday, 29'th May 2025
Moderna, Inc. (NASDAQ:MRNA ) Bernstein 41st Annual Strategic Decisions Conference Call May 29, 2025 10:00 AM ET Company Participants Stephane Bancel - CEO & Director Conference Call Participants Court
HHS cancels Moderna contract for development of bird flu vaccine for humans
12:15pm, Thursday, 29'th May 2025
The Department of Health and Human Services announced this week that it had canceled its contract with Moderna to develop a bird flu mRNA vaccine for humans. In a statement, the department wrote that
U.S. Govt. Cancels $766M Funding Contract for Moderna's Bird Flu Shot
12:10pm, Thursday, 29'th May 2025
The government scraps funding deal for MRNA's bird flu shot, despite encouraging safety and efficacy data from early clinical studies on the vaccine.
HHS cancels Moderna bird flu deal
08:47am, Thursday, 29'th May 2025
CNBC's Angelica Peebles joins 'Squawk Box' with the latest news.
US cancels more $700 million funding for Moderna bird flu vaccine
06:06pm, Wednesday, 28'th May 2025
The Trump administration has cancelled a contract awarded to Moderna for the late-stage development of its bird flu vaccine for humans, as well as the right to purchase shots, according to the drugmak
Moderna Announces Update on Investigational Pandemic Influenza Program
06:00pm, Wednesday, 28'th May 2025
Phase 1/2 H5 avian flu vaccine study shows positive interim results Company has been notified that HHS will terminate Moderna's award for late-stage development of pre-pandemic influenza vaccines CAMB
Cautious? Risky? Our Volatility Scorecard Can Help
10:13am, Tuesday, 27'th May 2025
Subscribers to Chart of the Week received this commentary on Sunday, May 11.
Moderna to Present at Upcoming Conferences in June 2025
07:00am, Tuesday, 27'th May 2025
CAMBRIDGE, MA / ACCESS Newswire / May 27, 2025 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conferences: Jefferies Global Health Care Conference,
MRNA Seeks FDA Nod for Updated COVID-19 Vaccine
10:46am, Monday, 26'th May 2025
Moderna files with FDA for updated Spikevax aimed at the LP.8.1 variant, which makes up 70% of U.S. COVID-19 cases.
